MIRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Mirum Pharmaceuticals Inc (MIRM) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, positive analyst sentiment, upcoming pivotal catalysts, and bullish technical indicators outweigh the short-term net loss and negative MACD signal. The stock is poised for long-term value creation, making it a suitable choice for the user's investment profile.
The stock's moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating a positive trend. However, the MACD histogram is negative (-1.186) and expanding downward, suggesting short-term bearish momentum. RSI is neutral at 21.509, and the stock is trading near its S1 support level of 93.843, which could provide a potential entry point.
Analysts maintain high price targets (ranging from $88 to $
with consistent Outperform/Buy ratings.
The company has strong commercial momentum with a 50% YoY revenue increase in Q4
Upcoming pivotal readouts in Primary Sclerosing Cholangitis and hepatitis delta virus could significantly expand its hepatology franchise.
Gross margin improved to 81.02%, indicating operational efficiency.
The company reported a net loss of $5.73 million in Q4 2025, and EPS dropped by 77.55% YoY.
MACD indicates short-term bearish momentum.
No significant hedge fund or insider trading trends were observed, suggesting neutral sentiment from key stakeholders.
In Q4 2025, revenue increased by 49.81% YoY to $148.93 million, demonstrating strong growth. However, net income fell to -$5.73 million (-75.91% YoY), and EPS dropped to -0.11 (-77.55% YoY). Gross margin improved to 81.02%, up 5.10% YoY, reflecting enhanced operational efficiency.
Analysts are highly optimistic about Mirum Pharmaceuticals, with multiple firms maintaining Outperform/Buy ratings and price targets ranging from $88 to $140. Analysts highlight the company's strong commercial momentum, upcoming pivotal catalysts, and potential for long-term value creation.
